BRFSS Asthma Call-back Survey Prevalence TABLE 10

TABLE 10. Estimated percent using inhaled short acting beta agonists among adults1 Click here to skip to citation 1 with current2 Click here to skip to citation 2 or active3 Click here to skip to citation 3 asthma status by state/territory - BRFSS Asthma Call-back Survey, United States, 2010
State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 302 56.2 4.1 (48.2 - 64.2) 317 54.8 4.2 (46.6 - 63.0)
Arizona 273 38.8 6.0 (27.0 - 50.6) 283 39.7 6.0 (27.9 - 51.5)
California 502 54.2 3.2 (47.9 - 60.5) 545 50.3 3.1 (44.2 - 56.4)
Connecticut 250 59.1 5.2 (48.9 - 69.3) 283 55.1 4.7 (45.9 - 64.3)
District of Columbia 134 53.3 5.8 (41.9 - 64.7) 151 51.2 5.5 (40.4 - 62.0)
Florida 414 47.7 4.9 (38.1 - 57.3) 449 45.9 4.9 (36.3 - 55.5)
Georgia 171 48.1 5.7 (36.9 - 59.3) 176 50.6 5.6 (39.6 - 61.6)
Hawaii 271 54.3 5.0 (44.5 - 64.1) 287 56.5 4.5 (47.7 - 65.3)
Illinois 166 66.9 5.5 (56.1 - 77.7) 173 64.5 5.4 (53.9 - 75.1)
Indiana 482 53.0 3.5 (46.1 - 59.9) 508 53.5 3.4 (46.8 - 60.2)
Iowa 261 48.4 4.5 (39.6 - 57.2) 270 45.6 4.4 (37.0 - 54.2)
Kansas 426 54.6 4.1 (46.6 - 62.6) 442 52.7 4.1 (44.7 - 60.7)
Louisiana 187 46.2 7.4 (31.7 - 60.7) 203 47.5 7.0 (33.8 - 61.2)
Maine 466 53.9 3.5 (47.0 - 60.8) 486 54.4 3.4 (47.7 - 61.1)
Maryland 256 43.3 5.8 (31.9 - 54.7) 284 42.3 5.6 (31.3 - 53.3)
Massachusetts 220 40.1 5.6 (29.1 - 51.1) 231 42.3 5.6 (31.3 - 53.3)
Michigan 540 56.5 3.4 (49.8 - 63.2) 573 54.3 3.3 (47.8 - 60.8)
Mississippi 330 51.1 4.4 (42.5 - 59.7) 339 49.1 4.2 (40.9 - 57.3)
Missouri 265 61.1 5.1 (51.1 - 71.1) 280 57.4 4.9 (47.8 - 67.0)
Montana 326 56.6 4.9 (47.0 - 66.2) 339 54.9 4.7 (45.7 - 64.1)
Nebraska 607 45.9 4.7 (36.7 - 55.1) 633 47.7 3.9 (40.1 - 55.3)
Nevada 143 57.7 6.5 (45.0 - 70.4) 168 49.9 6.2 (37.7 - 62.1)
New Hampshire 283 57.7 4.6 (48.7 - 66.7) 306 56.7 4.4 (48.1 - 65.3)
New Jersey 346 35.4 4.3 (27.0 - 43.8) 377 31.2 3.7 (23.9 - 38.5)
New Mexico 333 55.8 4.9 (46.2 - 65.4) 351 55.5 4.6 (46.5 - 64.5)
New York 133 51.8 6.0 (40.0 - 63.6) 145 52.4 5.7 (41.2 - 63.6)
North Dakota 178 55.0 5.7 (43.8 - 66.2) 185 53.9 5.6 (42.9 - 64.9)
Ohio 357 40.6 4.2 (32.4 - 48.8) 382 39.4 4.1 (31.4 - 47.4)
Oklahoma 343 60.2 4.2 (52.0 - 68.4) 365 57.6 4.1 (49.6 - 65.6)
Oregon 208 48.7 5.9 (37.1 - 60.3) 234 45.1 5.6 (34.1 - 56.1)
Pennsylvania 412 50.8 3.7 (43.5 - 58.1) 437 49.5 3.5 (42.6 - 56.4)
Rhode Island 326 51.6 4.5 (42.8 - 60.4) 349 49.7 4.3 (41.3 - 58.1)
Texas 651 54.8 4.6 (45.8 - 63.8) 721 51.4 4.6 (42.4 - 60.4)
Utah 438 40.9 4.3 (32.5 - 49.3) 460 43.4 3.9 (35.8 - 51.0)
Vermont 403 53.3 3.8 (45.9 - 60.7) 435 50.9 3.7 (43.6 - 58.2)
Washington 676 49.6 3.2 (43.3 - 55.9) 706 50.0 2.9 (44.3 - 55.7)
West Virginia 205 58.0 4.8 (48.6 - 67.4) 203 58.6 5.1 (48.6 - 68.6)
Wisconsin 221 63.4 5.0 (53.6 - 73.2) 243 58.2 5.0 (48.4 - 68.0)
Puerto Rico 118 42.2 9.9 (22.8 - 61.6) 159 35.2 7.2 (21.1 - 49.3)
39 state total 12,623 51.5 1.1 (49.3 - 53.7) 13,478 49.7 1.0 (47.7 - 51.7)
Median   53.3       50.9    
Range   35.4-66.9       31.2-64.5    

1 Aged ≥ 18 years

2 "Yes" response to "Do you still have asthma?"

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Sample size excludes "DK/Refused"

§ Standard error

Confidence interval